A reversible carnitine palmitoyltransferase (CPT1) inhibitor offsets the proliferation of chronic lymphocytic leukemia cells

• Elena Gugiatti,
• Claudya Tenca,
• Silvia Ravera,
• Marina Fabbi,
• Fabio Ghiotto,
• Andrea N. Mazzarello,
• Davide Bagnara,
• Daniele Reverberi,
• Daniela Zarcone,
• Giovanna Cutrona,
• Adalberto Ibatici,
• Ermanno Ciccone,
• Zbigniew Darzynkiewicz,
• Franco Fais,
• Silvia Bruno

Affiliations

Elena Gugiatti

Department of Experimental Medicine, University of Genoa, Italy

Claudya Tenca

Department of Experimental Medicine, University of Genoa, Italy

Silvia Ravera

Department of Pharmacy, University of Genoa, Italy

Marina Fabbi

Biotherapies Unit, Ospedale Policlinico San Martino, Genoa, Italy

Fabio Ghiotto

Department of Experimental Medicine, University of Genoa, Italy;Molecular Pathology Unit, Ospedale Policlinico San Martino, Genoa, Italy

Andrea N. Mazzarello

The Feinstein Institute for Medical Research, North Shore-Long Island, Experimental Immunology, Manhasset, NY, USA

Davide Bagnara

Department of Experimental Medicine, University of Genoa, Italy;The Feinstein Institute for Medical Research, North Shore-Long Island, Experimental Immunology, Manhasset, NY, USA

Daniele Reverberi

Molecular Pathology Unit, Ospedale Policlinico San Martino, Genoa, Italy

Daniela Zarcone

Department of Experimental Medicine, University of Genoa, Italy

Giovanna Cutrona

Molecular Pathology Unit, Ospedale Policlinico San Martino, Genoa, Italy

Adalberto Ibatici

Hematology Unit and Bone Marrow Transplantation, Ospedale Policlinico San Martino, Genoa, Italy

Ermanno Ciccone

Department of Experimental Medicine, University of Genoa, Italy

Zbigniew Darzynkiewicz

Brander Cancer Research Institute, Department of Pathology, New York Medical College, NY, USA

Franco Fais

Department of Experimental Medicine, University of Genoa, Italy;Molecular Pathology Unit, Ospedale Policlinico San Martino, Genoa, Italy

Silvia Bruno

Department of Experimental Medicine, University of Genoa, Italy